Related Experiment Video
Updated: Aug 10, 2026

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma
K K C Li1, J Goodall, C R Goding
1Department of Biology, HK University of Science & Technology, Kowloon, HK, China.
Abstract:
Clear cell sarcoma (CCS) is associated with the EWS/ATF1 oncogene that is created by chromosomal fusion of the Ewings Sarcoma oncogene (EWS) and the cellular transcription factor ATF1. The melanocytic character of CCS suggests that the microphthalmia-associated transcription factor (Mitf), a major inducer of melanocytic differentiation, may be miss-expressed in CCS. Accordingly, we show that the mRNA and protein of the melanocyte-specific isoform of Mitf (Mitf-M) are present in several cultured CCS cell lines (Su-ccs-1, DTC1, Kao, MST-1, MST-2 and MST-3). The above cell lines thus provide a valuable experimental resource for examining the role of Mitf-M in both CCS and melanocyte differentiation. Melanocyte-specific expression of Mitf-M is achieved via an ATF-dependent melanocyte-specific cAMP-response element in the Mitf-M promoter, and expression of Mitf-M in CCS cells suggests that EWS/ATF1 (a potent and promiscuous activator of cAMP-inducible promoters) may activate the Mitf-M promoter. Surprisingly, however, the Mitf-M promoter is not activated by EWS/ATF1 in transient assays employing CCS cells, melanocytes or nonmelanocytic cells. Thus, our results indicate that Mitf-M promoter activation may require an appropriate chromosomal context in CCS cells or alternatively that the Mitf-M promoter is not directly activated by EWS/ATF1.
Insights
Clear cell sarcoma (CCS) cells express the melanocyte-specific microphthalmia-associated transcription factor (Mitf-M). However, the EWS/ATF1 oncogene does not directly activate the Mitf-M promoter in CCS cells.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Clear cell sarcoma (CCS) is characterized by the EWS/ATF1 oncogene, a fusion of the Ewings Sarcoma oncogene (EWS) and ATF1.
- The melanocytic nature of CCS suggests a potential role for the microphthalmia-associated transcription factor (Mitf), a key regulator of melanocyte differentiation.
Purpose of the Study:
- To investigate the expression and regulation of the melanocyte-specific Mitf isoform (Mitf-M) in CCS.
- To determine if the EWS/ATF1 oncogene activates the Mitf-M promoter in CCS.
Main Methods:
- Cultured CCS cell lines (Su-ccs-1, DTC1, Kao, MST-1, MST-2, MST-3) were used to analyze Mitf-M mRNA and protein expression.
- Transient transfection assays were performed in CCS cells, melanocytes, and non-melanocytic cells to assess Mitf-M promoter activity driven by EWS/ATF1.
Main Results:
- Mitf-M mRNA and protein were detected in multiple cultured CCS cell lines.
- Contrary to expectations, EWS/ATF1 did not activate the Mitf-M promoter in transient assays across different cell types.
Conclusions:
- Cultured CCS cell lines expressing Mitf-M serve as a valuable model for studying Mitf-M in CCS and melanocyte differentiation.
- The findings suggest that Mitf-M promoter activation in CCS may depend on a specific chromosomal context or that EWS/ATF1 does not directly regulate the Mitf-M promoter.
More Related Videos
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...